Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.

Literature DB >> 19814686

Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.

Sarah T Wilkinson, Diane R Fernandez, Shawn P Murphy, Rita M Braziel, Elias Campo, Wing C Chan, Jan Delabie, Randy D Gascoyne, Louis M Staudt, Elaine S Jaffe, Andreas Rosenwald, Lisa M Rimsza.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2009 PMID： 19814686 PMCID： PMC2988580 DOI： 10.3109/10428190903297531

Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022

× No keyword cloud information.

15 in total

1. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.

Authors: M Frommer; L E McDonald; D S Millar; C M Collis; F Watt; G W Grigg; P L Molloy; C L Paul
Journal: Proc Natl Acad Sci U S A Date: 1992-03-01 Impact factor: 11.205

2. CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression.

Authors: Lisa M Rimsza; Wing C Chan; Randy D Gascoyne; Elias Campo; Elaine S Jaffe; Louis M Staudt; Jan Delabie; Andreas Rosenwald; Shawn P Murphy
Journal: Haematologica Date: 2009-02-19 Impact factor: 9.941

3. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

Authors: A Muhlethaler-Mottet; L A Otten; V Steimle; B Mach
Journal: EMBO J Date: 1997-05-15 Impact factor: 11.598

4. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).

Authors: V Steimle; L A Otten; M Zufferey; B Mach
Journal: Cell Date: 1993-10-08 Impact factor: 41.582

5. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.

Authors: A C Morris; W E Spangler; J M Boss
Journal: J Immunol Date: 2000-04-15 Impact factor: 5.422

6. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.

Authors: Lisa M Rimsza; Robin A Roberts; Thomas P Miller; Joseph M Unger; Michael LeBlanc; Rita M Braziel; Dennis D Weisenberger; Wing C Chan; H Konrad Muller-Hermelink; Elaine S Jaffe; Randy D Gascoyne; Elias Campo; Deborah A Fuchs; Catherine M Spier; Richard I Fisher; Jan Delabie; Andreas Rosenwald; Louis M Staudt; Thomas M Grogan
Journal: Blood Date: 2004-02-19 Impact factor: 22.113

7. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors: Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal: N Engl J Med Date: 2002-06-20 Impact factor: 91.245

8. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.

Authors: Ann C Morris; Guy W Beresford; Myesha R Mooney; Jeremy M Boss
Journal: Mol Cell Biol Date: 2002-07 Impact factor: 4.272

9. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets.

Authors: R S Accolla
Journal: J Exp Med Date: 1983-03-01 Impact factor: 14.307

10. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.

Authors: Y Morimoto; M Toyota; A Satoh; M Murai; H Mita; H Suzuki; Y Takamura; H Ikeda; T Ishida; N Sato; T Tokino; K Imai
Journal: Br J Cancer Date: 2004-02-23 Impact factor: 7.640

6 in total

1. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.

Authors: Sarah T Wilkinson; Kristie A Vanpatten; Diane R Fernandez; Patrick Brunhoeber; Karl E Garsha; Betty J Glinsmann-Gibson; Thomas M Grogan; Julie Teruya-Feldstein; Lisa M Rimsza
Journal: Blood Date: 2011-12-13 Impact factor: 22.113

2. Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma.

Authors: Samantha Kendrick; Lisa M Rimsza; David W Scott; Graham W Slack; Pedro Farinha; King L Tan; Daniel Persky; Soham Puvvada; Joseph M Connors; Laurie Sehn; Randy D Gascoyne; Monika Schmelz
Journal: Virchows Arch Date: 2016-11-25 Impact factor: 4.064